The NF-2 does not matter

Understanding NF-2 Timing in EUO Scheduling Requirements

Understanding the timing requirements for Examinations Under Oath (EUOs) in New York No-Fault Insurance Law cases can be complex, particularly when it comes to the role of NF-2 forms. A recent Appellate Term decision provides important clarity on when insurance companies must schedule EUOs and whether receipt of the NF-2 form affects these timing obligations.

The case of Excel Products, Inc. v Ameriprise Auto & Home demonstrates a common misconception among practitioners about EUO scheduling requirements. Many assume that insurance companies must wait to receive the NF-2 form before scheduling examinations, but this decision confirms that’s not always the case. When claims are denied within the statutory 30-day period and EUOs have been properly scheduled, the timing of NF-2 receipt becomes irrelevant.

This ruling has significant implications for no-fault practitioners who often focus heavily on NF-2 timing issues in their litigation strategy.

New York’s no-fault regulatory scheme establishes detailed procedural requirements for how insurance companies process claims. The NF-2 form serves as a verification request that insurers may send to providers to obtain additional information about claims. Providers must respond within specified timeframes or risk claim denials for failing to cooperate with investigations. However, insurers are not required to wait for NF-2 submissions before taking other investigation steps, including scheduling EUOs.

Case Background

Excel Products, Inc. sued Ameriprise Auto & Home Insurance for unpaid no-fault benefits after the insurer denied claims based on the provider’s failure to appear for scheduled EUOs. The provider challenged the denials, arguing that Ameriprise improperly scheduled the EUOs before receiving the provider’s NF-2 responses. According to this theory, insurers must wait for NF-2 submissions before proceeding with EUO scheduling, and any EUOs scheduled prematurely are procedurally invalid.

The trial court rejected this argument, and the provider appealed. The Appellate Term, Second Department affirmed, holding that when insurers deny claims within 30 days and schedule EUOs before that deadline expires, the timing of NF-2 receipt does not affect the validity of the EUO requests.

Jason Tenenbaum’s Analysis:

Excel Prods., Inc. v Ameriprise Auto & Home, 2021 NY Slip Op 50435(U)(App. Term 2d Dept. 2021)

“As a result, defendant established its prima facie entitlement to summary judgment dismissing the complaint (see Interboro Ins. Co. v Clennon, 113 AD3d at 597). Defendant did not need to toll its time to pay or deny the claims at issue, as they were denied within 30 days of defendant’s receipt of same, and the EUOs had been scheduled prior to defendant’s receipt of plaintiff’s claims. Consequently, plaintiff’s contention that defendant needed, but failed, to demonstrate that the EUO scheduling letters were timely mailed after defendant’s receipt of the NF-2 form lacks merit and is contrary to Insurance Law article 51 and the regulations promulgated thereunder”

I post this here because of the NF-2 confusion that plays out. 2x no show prior to receipt of bill + timely disclaimer = loser.

Legal Significance: Decoupling NF-2 Receipt from EUO Scheduling

The Excel Products decision clarifies an important point of regulatory interpretation: the NF-2 process and EUO scheduling operate on independent timelines when insurers act promptly to deny claims. Insurers need not wait for verification responses before initiating other investigative steps, including scheduling examinations under oath.

This holding reflects practical realities of claims administration. No-fault insurers often receive multiple forms of information about claims simultaneously or in quick succession. Requiring sequential processing — waiting for each verification response before taking next investigative steps — would unnecessarily delay legitimate fraud detection efforts while providing no corresponding benefit to claimants or providers.

The decision emphasizes that timely denials within the regulatory 30-day window obviate certain timing requirements. When insurers act within this initial period, they need not engage in the tolling provisions that apply when claims processing extends beyond 30 days. EUOs scheduled during this initial window are valid regardless of whether NF-2 forms have been received or responded to.

However, the ruling leaves open different scenarios. When insurers miss the 30-day denial deadline and seek to toll their time through verification requests, the relationship between NF-2 timing and subsequent EUO scheduling may become relevant. The decision specifically addresses the scenario where prompt action was taken, not cases involving delayed processing.

Jason Tenenbaum’s shorthand summary captures the practical import: when providers no-show EUOs that were scheduled before bills were even received, and insurers timely disclaim coverage, providers’ challenges to EUO timing based on NF-2 receipt fail. This combination effectively defeats claims regardless of verification timing issues.

Practical Implications for Claims Handling

Insurance carriers should recognize that prompt claim denial and early EUO scheduling provides maximum procedural protection. By acting within the initial 30-day period, insurers avoid complicated timing calculations about verification responses and tolling provisions. Claims handlers should prioritize quick decisions about whether to schedule EUOs rather than waiting for verification information when fraud or cooperation concerns exist.

Medical providers cannot rely on NF-2 timing arguments to challenge EUO-based denials when insurers acted within the 30-day window. Providers facing such denials should focus arguments on substantive EUO issues rather than procedural timing disputes about verification forms. When insurers schedule EUOs early in the claims process, NF-2 timing provides no viable defense.

Trial courts should carefully analyze the specific timing sequence when providers raise NF-2-related challenges to EUO denials. The Excel Products rule applies when denials occur within 30 days and EUOs are scheduled during that period, but different timing scenarios may warrant different analysis under regulatory tolling provisions.

Key Takeaway

When insurance companies deny no-fault claims within 30 days and schedule EUOs before receiving bills, the timing of NF-2 form receipt doesn’t matter. This case reinforces that proper denial procedures combined with timely EUO scheduling can defeat claims even when procedural timing arguments are raised.

Related Articles

• No-Fault attorney
• It is the bill, not the NF-2
• A valid NF-10